ESR1 and neoplasm: Importantly, comprehensive analysis of the cell cycle using Ki67, the MPI algorithm, and transcriptomic data, provides evidence that, in the presence of an ESR1 mutation, better ER targeting is associated with increased cell cycle inhibition and potentiates tumor growth suppression.